As noted above, significant evidence now supports a role for UCHL1 as a driver of several types of breast cancers; however, this protein has until recently lacked selective and potent small-molecule inhibitors or ABPs, limiting opportunities to explore the translational potential of these findings. The gene discussed is UCHL1; the disease is breast carcinoma.